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The antiviral response is largely mediated by
dendritic cells (DCs), including conventional (c) DCs
that function as antigen-presenting cells, and plas-
macytoid (p) DCs that produce type I interferons,
making them an attractive target for viruses. We
find that the Old World arenaviruses lymphocytic
choriomeningitis virus clone 13 (LCMV Cl13) and
Lassa virus bind pDCs to a greater extent than
cDCs. Consistently, LCMV Cl13 targets pDCs early
after in vivo infection of its natural murine host and
establishes a productive and robust replication
cycle. pDCs coproduce type I interferons and proin-
flammatory cytokines, with the former being induced
in both infected and uninfected pDCs, demonstrat-
ing a dissociation from intrinsic virus replication.
TLR7 globally mediates pDC responses, limits pDC
viral load, and promotes rapid innate and adaptive
immune cell activation. These early events likely
help dictate the outcome of infections with arenavi-
ruses and other DC-replicating viruses and shed light
on potential therapeutic targets.
INTRODUCTION
Dendritic cells (DCs) are a heterogeneous population, exhibiting
unique and overlapping functions in the orchestration of
immune responses. Conventional DCs (cDCs) can be subdi-
vided into CD11b+ and CD11b (CD8+) cDCs and function as
professional antigen-presenting cells (Banchereau and Stein-
man, 1998; Shortman, 2000). In contrast, plasmacytoid DCs
(pDCs) are specialized to produce large amounts of the antiviral
mediator type I interferon (IFN-I) and synthesize a broad range
of IFN-I isoforms following microbial stimulation (Reizis et al.,
2011; Swiecki and Colonna, 2010). pDCs exert multiple other
functions, including IL-12 production, which along with IFN-I
can activate natural killer (NK) and T cells (Swiecki and Colonna,
2010). Because IFN-I can inhibit IL-12 production (Cousens
et al., 1997; McRae et al., 1998), it is possible that distinct,Cell Hmutually exclusive pDC maturation stages or subtypes secrete
these cytokines. pDCs can also present antigens during in-
fection with several viruses, albeit not as powerfully as cDCs
(Villadangos and Young, 2008). Finally, pDCs are infected
by human immunodeficiency virus (HIV) (Fitzgerald-Bocarsly
and Jacobs, 2010) and can uptake hepatitis B virus (HBV)
(Untergasser et al., 2006), but the functional consequences of
these events remain unclear. In sum, pDCs play important roles
in both innate and adaptive immune responses, and under-
standing the interactions between pDCs and viruses is of great
significance.
Arenaviruses include several causative agents of severe
hemorrhagic fevers in humans, causing hundreds of thousands
of disease cases each year in Africa and South America, as well
as lymphocytic choriomeningitis virus (LCMV), a prevalent
human pathogen with worldwide distribution (McCormick and
Fisher-Hoch, 2002; Oldstone, 2002). New pathogenic arenavi-
ruses are continuously emerging (Geisbert and Jahrling, 2004),
and with no licensed vaccines, only limited treatments available,
and the threat of misuse for bioterrorism, arenaviruses repre-
sent a serious health concern. LCMV is the prototypic member
of the arenaviridae family, causing fatal illness in immunocom-
promised individuals and congenital brain malformation associ-
ated with mental retardation in infants (Barton et al., 2002;
Peters, 2006). Like other arenaviruses, LCMV is a nonlytic envel-
oped virus with two negative stranded RNA segments (Meyer
et al., 2002). The small segment encodes the viral nucleoprotein
(NP) and glycoprotein (GP) precursors, while the large seg-
ment encodes the RNA-dependent RNA polymerase (L) and
the matrix protein (Z). The surface of LCMV displays evenly
distributed GP heterotrimers that bind to the cellular receptor
a-dystroglycan (a-DG), which is shared by all Old World arena-
viruses, including the highly pathogenic Lassa virus (LASV)
(Rojek and Kunz, 2008).
Among LCMV variants, LCMV clone 13 (Cl13) is of particular
interest as it outcompetes the ensuing immune response, result-
ing in chronic infection (Ahmed et al., 1984). Therefore, LCMV
Cl13 has served as a model both for arenaviruses that outpace
the human immune system, such as LASV, and for viruses that
establish chronic infections such as HIV, HCV, and HBV (Old-
stone, 2007; Zinkernagel, 2002). The ability of LCMV Cl13 to
outcompete its host has been related to a F > Lmutation at posi-
tion 260 of the GP, which enhances its binding affinity to a-DGost & Microbe 11, 617–630, June 14, 2012 ª2012 Elsevier Inc. 617
Cell Host & Microbe
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fibroreticular cells, and a K > Q mutation at position 1,079 of
the viral polymerase that increases viral replicative capacity
(Bergthaler et al., 2010; Matloubian et al., 1993; Mueller et al.,
2007; Sullivan et al., 2011).
In the present study, we investigated early pDC responses
upon in vivo infection with LCMV Cl13. We found that, consis-
tent with their capacity to preferentially bind to LCMV Cl13
and LASV GP, pDCs became rapidly infected with LCMV Cl13
to a higher degree than other leukocytes and were powerful
producers of both IFN-I and IL-12. Intrinsic virus replication
was not a requisite for pDC IFN-I production, as uninfected
(rather than infected) pDCs were numerically a greater source
of IFN-I. Instead, pDC responses were globally mediated by
TLR7, which limited their viral loads and promoted early activa-
tion of innate and adaptive immune cells. Our study aids the
understanding of diseases caused by the highly pathogenic are-
naviruses and other viruses that productively target and repli-
cate within DCs.
RESULTS
LCMV and LASV Glycoprotein Preferentially Bound to
pDCs
Among splenic leukocytes, DCs express the highest levels of
functional a-DG, consistent with DCs being a major target of
LCMV Cl13 and LASV (Baize et al., 2004; Sevilla et al., 2003).
To further discern Old World arenavirus tropism within the het-
erogeneous DC population, we assessed binding of LCMV
Cl13 and a pseudoviral particle that expressed LASV GP
(LASV-GP) to proteins isolated from bone marrow (BM)-derived
pDCs and cDCs generated in the presence of fms-like tyrosine
kinase receptor-3 ligand (Flt3L) or granulocyte macrophage
colony-stimulating factor (GM-CSF) (Figure 1A). We observed
that both LCMV Cl13 and LASV-GP bound to pDCs to a greater
extent than GM-CSF- and Flt3L-derived cDCs, which exhibited
lower or undetectable binding, respectively (Figure 1B). pDCs
also expressed higher levels of LCMV NP than cDCs from
Flt3L cultures generated from BM of infected mice (Figure 1C).
To confirm these findings, splenic pDCs and cDCs (CD8+ and
CD11b+ cDCs) were FACS purified from uninfected mice as indi-
cated in Figure 1D, and protein lysates were assessed for
binding to LCMV Cl13 and recombinant LCMV expressing the
GP of LASV (rLCMV-LASV GP) (Rojek et al., 2008) (Figure 1E).
Similar to BM-pDCs, ex vivo splenic pDCs bound both LCMV
Cl13 and rLCMV-LASV-GP to a higher level than CD8+ and
CD11b+ cDC subsets. Altogether, these results indicated that
pDCs expressed a functional receptor(s) and exhibited greater
binding to Old World arenavirus GPs than cDCs, suggesting
that they could be preferential and important targets upon
LCMV Cl13 and LASV exposure.
LCMV Cl13 Productively Infected pDCs Early after
In Vivo Exposure
To investigate the degree of pDC infection in relation to other
leukocytes early after in vivo exposure with LCMV Cl13, we
purified splenic pDCs, CD8+ and CD11b+ cDCs, macrophages,
and B and T cells at day 1 p.i. We found that pDCs exhibited
the highest degree of LCMV Cl13 infection compared to the618 Cell Host & Microbe 11, 617–630, June 14, 2012 ª2012 Elsevieraforementioned leukocytes, as indicated by elevated levels
of LCMV glycoprotein LCMVsSgp1 (gp) and nucleoprotein
LCMVsSgp2 (np) RNA transcripts (Figure 2A and data not
shown). We validated these findings by infecting WT mice
with a recombinant LCMV Cl13 virus that encodes green fluo-
rescent protein (r3LCMVCl13-GFP) (Emonet et al., 2009) and
analyzed GFP+ DCs at day 1 p.i. We observed that CD11c+
CD11blo/negPDCA+ cells comprised the majority of GFP+ DCs
(GFP+), while they represented about one third of the GFP
DCs (GFP) (Figure 2B). Of note, B220 expression was interme-
diate in this GFP+ population (data not shown). To examine
productive viral infection in pDCs, we performed infectious
center assays. pDCs released significantly higher numbers of
infectious particles as compared to the other leukocyte popula-
tions (Figure 2C). Of note, at day 5 p.i., pDCs continued being
productive targets of LCMV Cl13, but at this latter stage cDCs
also showed similarly high levels of infection (see Figure S1
available online). These data indicated that LCMV Cl13 rapidly
infected pDCs to a significantly higher extent than other splenic
leukocytes analyzed in this study, establishing a productive viral
life cycle in vivo.
pDCs Were Powerful IFN-I and IL-12 Producers Early
after LCMV Cl13 Infection
pDC IFN-I response is silenced by day 5 of LCMV Cl13 infection
(Lee et al., 2009; Zuniga et al., 2008), but whether pDCs pro-
duced IFN-I early after infection with the pDC-tropic LCMV
Cl13 remained unknown. Analysis of ifna 4, 6, 7 (ifna) and
ifnb1 RNA in splenocytes, obtained at day 1 after LCMV Cl13
infection, revealed the highest levels of IFN-I transcript in
pDCs (Figure 3A). Accordingly, IFN-I bioactivity was signifi-
cantly elevated in culture supernatants of pDCs from LCMV
Cl13-infected, compared to uninfected, mice (Figure 3B). To
confirm and extend these findings, we infected IFNbmob/mob
mice, which express yellow fluorescent protein (YFP) under
the ifnb1 promoter (Scheu et al., 2008), with LCMV Cl13. We
observed that pDCs were the most potent IFNb-producing cells
in spleen, BM, peripheral (p), and mesenteric (m) lymph nodes
(LNs), as indicated by the highest percentages of YFP+ cells
in pDCs among all leukocytes analyzed (Figure 3C and Fig-
ure S2A). Consistently, 80% of YFP+ cells exhibited a pDC
phenotype (Figure S2B). pDCs also produced multiple cyto-
kines (i.e., IL-12, TNFa, IL1a) as well as chemokines (i.e.,
MCP1, MIP1b, and RANTES) in response to infection (Fig-
ure S2C). We further studied IL-12 and TNFa production by
flow cytometry. We found that a substantial fraction of splenic
pDCs synthesized IL-12, to levels above cDCs and macro-
phages, suggesting pDCs are a major producer of IL-12 at
this early time point (Figure 3D and Figure S2D), whereas
CD11b+ cDCs outnumbered pDCs when total TNFa-producing
cells were enumerated in the spleen (Figure 3D and Figure S2D).
Finally, to assess whether different pDC subsets were respon-
sible for distinct cytokine secretion, we analyzed IL-12 and
TNFa production in pDCs from IFNbmob/mob mice. We detected
that 30%–45% of IFNb-producing pDCs were coproducing
IL-12, while a minor or undetectable fraction of these dual
producers were synthesizing TNFa (Figure 3E). Altogether,
these data indicated that pDCs were powerful IFN-I-producing
cells in several lymphoid tissues, with a proportion of themInc.
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Figure 1. pDCs Express High Levels of Old World Arenavirus Binding Proteins
(A–C) BM cells from uninfected (A and B) or day 3 LCMV Cl13 infected mice (C) were cultured with GM-CSF to generate cDCs or Flt3L to generate pDCs and
cDCs. (A). At days 8–10 postculture, pDCs were identified as CD11c+CD11bB220+PDCA+ and cDCs were identified as CD11c+CD11b+B220 (Flt3L) and
CD11c+CD11b+ (GM-CSF). (B) pDCs and cDCs were processed for virus overlay assay with LCMV Cl13 or LASV-GP. Virus binding to pDC or cDC protein
homogenates is shown at 165 kDa, similar to the molecular weight for a-DG. (C) At day 4 postculture, Flt3L BM cultures were stained with anti-LCMV-NP Ab and
analyzed by flow cytometry. Data are representative of two to three experiments.
(DandE)SplenicpDCs (T-B-NKCD11c+CD11bB220+PDCA+),CD11b+cDCs (T-B-NKCD11c+CD11b+B220), andCD8+cDCs (T-B-NKCD11c+CD11bB220
CD8+) (D) were purified from uninfected mice, and protein lysates were analyzed for LCMV Cl13 and LASV GP (rLCMV-LASV GP) binding, measured by
virus binding assay (E). Spleens were pooled from five mice in two independent experiments. Bar graphs depict the mean ± SD. *p < 0.05, **p < 0.001,
***p < 0.0001.
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Figure 2. Rapid and Productive pDC Infec-
tion by LCMV Cl13 In Vivo
C57Bl/6 (WT) mice were infected with WT LCMV
Cl13 (A and C) or r3LCMVCl13-GFP (Cl13-GFP; B).
Spleens were pooled from three to five mice per
group at day 1 p.i. and processed for FACS
purification of pDCs, CD8+ and CD11b+ cDCs,
and macrophages as described in Figure 1D. (A)
LCMV gp and np RNA levels were determined
relative to gapdh by qPCR. Bar graph depicts the
mean ± SD of triplicates. (B) The percentage of
CD11c+PDCA+CD11blo/neg cells within GFP+ and
GFP DCs was evaluated by flow cytometry.
Representative plots are shown. Graph depicts
the percentage of PDCA+CD11blo/neg cells within
DC gate, where circles represent individual
mice. (C) Infectious center assay determined the
number of productively infected cells per million
cells. Bar graphs depict the mean ± SD. All
results are representative of three to four experi-
ments with three to five mice per group. p < 0.05,
**p < 0.001, ***p < 0.0001. See also Figure S1.
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in vivo LCMV Cl13 infection.
pDCs Matured but Remained Poor Antigen-Presenting
Cells after LCMV Cl13 Infection
Because pDCs were productively infected and rapidly
secreted immune-activating cytokines, we investigated their
antigen-presenting capacity. pDCs significantly upregulated
major histocompatibility complex (MHC) I, MHC II, CD86, pro-
grammed death ligand 1 (PDL1), and CD40 expression at day 1
after LCMV Cl13 infection in comparison to uninfected controls
and infected macrophages, albeit to a lesser extent than cDCs
(Figure 4A and Figure S3). Notably, YFP+ and YFP pDCs from
LCMV Cl13-infected IFNbmob/mob mice exhibited similar upregu-
lation of MHC II and CD86 (Figure 4B), suggesting different
requirements for pDC IFN-I production and maturation. Next,
we directly tested the ability of pDCs to prime naive LCMV-
specific T cells in comparison with other antigen-presenting
cells. In contrast to pDCs, cDCs from infected mice successfully
induced T cell proliferation and cytokine production in both
LCMV-specific CD8+ (higher induction by CD8+cDC) and CD4+
(higher induction by CD11b+cDC) T cells (Figure 4C). No prolifer-
ation or cytokine production was induced by DCs from unin-
fectedmice (data not shown). These results indicated that, unlike
cDCs and despite upregulated maturation markers early after
infection, pDCs remained weak antigen-presenting cells to
both naive CD4+ and CD8+ T cells.620 Cell Host & Microbe 11, 617–630, June 14, 2012 ª2012 Elsevier Inc.pDC IFN-I Production and
Maturation Were Dissociated from
Intrinsic LCMV Replication
Arenavirus NPs are powerful inhibitors
of IFN-I production (Martinez-Sobrido
et al., 2006). To test the effect of intrinsic
LCMV replication on early pDC IFN-I pro-
duction, we infected WT or IFNbmob/mob
mice with r3LCMVCl13-GFP or WT Cl13.
The proportions of YFP+ or YFP pDCs
and cDCs that were infected (GFP+) or uninfected (GFP) were
analyzed. A similar proportion of both GFP+ and GFP pDCs
produced IFNb, although uninfected pDCs producing IFNb
were more numerous (Figure 5A). In contrast, only infected
(GFP+) cDCs appeared to be producing IFNb, suggesting that
cDCs required intrinsic viral replication for IFN-I induction (Fig-
ure 5A and Figure S4). We confirmed IFN-I production in infected
pDCsby injecting IFNbmob/mobmicewithWTLCMVCl13 followed
by FACS purification of YFP+ and YFP pDCs. We observed that
IFNb-YFP+ pDCs expressed higher transcript levels of LCMV gp
and np (Figure 5B) and exhibited a tendency toward increased
numbers of infectious viral particles produced per pDC when
compared to YFP pDCs (Figure 5C). Lastly, we determined by
immunofluorescence microscopy the localization of IFNb-pro-
ducing, as well as LCMV-infected, cells in the spleen (Figure 5D).
LCMV+ cells were located primarily bordering lymphoid follicles
of the spleen, as previously reported (Borrow et al., 1995), and
YFP+ cells were roughly within the same areas. In agreement
with the above flow cytometric data, YFP+ signal was readily
detected in both infected and uninfected cells (Figure 5D). Alto-
gether, these data provided in vivo evidence that pDCs do not
require intrinsic viral replication to secrete IFN-I and that unin-
fected (rather than infected) pDCs were quantitatively a major
source of IFN-I at the peak of its response. Notably, pDC IFN-I
production was not completely inhibited by intrinsic LCMV repli-
cation, but the majority of infected pDCs (and cDCs) did not
induce IFN-I in response to the intrinsically replicating virus.
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Figure 3. Early pDC Cytokine Production during LCMV Cl13 Infection
WT (A, B, and D) and IFNbmob/mob (C and E) mice were left uninfected or infected with LCMVCl13 and sacrificed at day 1 p.i. (A) Spleens were pooled from three to
five mice per group and processed for FACS purification. Ifna and Ifnb1 RNA transcript levels were determined relative to gapdh by qPCR. (B) Splenic FACS-
purified pDCs from uninfected (white bar) and LCMVCl13 infected (gray bar) mice were cultured for 15 hr in media. IFN-I levels in supernatants weremeasured by
bioassay. (C) YFP expression was analyzed by flow cytometry in pDCs, CD11b+cDCs (CD11c+B220CD11b+), CD11bcDCs (CD11c+B220CD11b), and
macrophages from spleen, BM, pLN, and mLN of WT and IFNbmob/mob Cl13 infected mice. Representative histograms from uninfected (gray solid) and infected
(black unfilled) mice are shown. Bar graphs depict percentage of YFP+ cells per cell type in lymphoid tissues. (D) IL-12p40 and TNFa production in splenic pDCs,
CD11b+ and CD11bcDCs, and macrophages was determined by flow cytometry. Representative dot plots for uninfected and infected mice are shown. Bar
graphs depict percentage of IL-12p40+ and TNFa+ cells. (E) YFP+ splenocytes from IFNbmob/mob infected mice were analyzed for IL-12p40 and TNFa expression
by flow cytometry. Representative dot plots are shown. Bar graphs depict percentage of IL-12p40+ and TNFa+ cells within YFP+ cells. All bar graphs depict
mean ± SD, and data are representative of two to three experiments with four to five mice per group. *p < 0.05, **p < 0.001, ***p < 0.0001. See also Figure S2.
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Figure 4. pDCs Mature but Remain Poor Antigen-Presenting Cells during LCMV Cl13 Infection
WT (A–C) and IFNbmob/mob (B) mice were left uninfected or infected with LCMV Cl13, and splenocytes were obtained at day 1 p.i. (A) MHC I, MHC II, CD86, PDL1,
and CD40 expression in pDCs was determined by flow cytometry. Representative histograms of uninfected (gray solid) and infected (black unfilled) mice are
shown. Graphs depict mean ± SD of mean fluorescence intensity (MFI) for indicated molecules, where symbols represent individual mice. (B) MHC II and CD86
expression was analyzed by flow cytometry in YFP and YFP+ pDCs from IFNbmob/mob infected mice. Representative histograms for uninfected pDC (gray
unfilled) and infected YFP (gray solid) and YFP+ (black unfilled) pDCs are shown. Bar graphs depict mean ± SD ofMFI for indicatedmolecules. (C) pDCs, CD11b+
and CD8+cDCs, andmacrophages were FACS purified from pooled splenocytes of infectedmice and cocultured with CFSE-labeled naive P14 CD8+ or SMARTA
CD4+ T cells for 72 hr. T cells were analyzed for proliferation (CFSE) and TNFa or IL-2 production by P14 and SMARTA cells, respectively. All results are
representative of two to four experiments with four to five mice per group. *p < 0.05, **p < 0.001, ***p < 0.0001. See also Figure S3.
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Figure 5. pDCs Produce IFN-I Independent
of Intrinsic LCMV Cl13 Replication
WT or IFNbmob/mob mice were left uninfected or
infected with either Cl13-GFP (A) or WT LCMV
Cl13 (B–D), and spleens were processed at
day 1 p.i. (A) YFP signal was analyzed by flow
cytometry in infected (GFP+) and uninfected
(GFP) PDCA-enriched pDCs and cDCs. Repre-
sentative dot plots are shown. (B and C) Spleens
were pooled from four to five mice per group for
FACS purification of YFP+ and YFP pDCs. LCMV
gp and np RNA transcript levels were determined
relative to gapdh. (B) Productively infected YFP+
versus YFP pDCs were quantified by infectious
center assay. (C) Bar graphs represent mean ± SD.
(D) Spleens were evaluated for IFNb (green) and
LCMV Cl13 (red) localization by confocal micros-
copy. Nuclei are stained with DAPI (blue). White
arrows indicate IFNb-producing and Cl13-infected
cells (middle panel) and double positive-stained
cells (right panel). All bar graphs depict mean ± SD,
and results are representative of two to three
independent experiments with three to five mice
per group. *p < 0.05, **p < 0.001, ***p < 0.0001. See
also Figure S4.
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Cl13 Infection
A previous study proposed that pDCs may use a MyD88-
dependent and partially TLR7/9-independent pathway to sense
LCMV in vivo (Jung et al., 2008), while another study demon-
strated that pDCs produce IFN-I in response to transfected
LCMV RNA in a MyD88-independent manner (Zhou et al.,
2010). To shed light on this issue, we investigated systemic
and pDC-derived IFN-I production in WT versus TLR7/
LCMV-Cl13-infected mice at day 1 p.i. TLR7/ mice exhibited
significantly reduced levels of serum IFN-I, although substantial
levels were still detected (Figure 6A). In contrast, ifna and ifnb
RNA expression in pDCs and IFN-I bioactivity in pDC culture
supernatants were completely ablated in the absence of TLR7
(Figures 6B and 6C). Only background levels of ifna and ifnb1
transcript were detected in cDCs and macrophages from both
WT and TLR7/ infected mice. Similarly, IL-12 levels wereCell Host & Microbe 11, 617–6significantly decreased in pDC culture
supernatants and flow cytometric analysis
in TLR7/ compared toWT infectedmice
(Figures 6D and 6E). We also observed
that the TLR7/ pDCs exhibited signifi-
cantly lower levels of MHC II, CD86, and
PDL1 compared toWT infected mice (Fig-
ure 6F). Finally, we investigated viral loads
in pDCs fromWTand TLR7/mice at day
1 p.i. We found that pDCs from TLR7/
infected mice had enhanced levels of
LCMV gp and np transcripts in com-
parison to WT controls (Figure 6G). These
findings demonstrated that TLR7 played
a central role in pDC recognition of
LCMV, mediating rapid pDC maturation
and production of IFN-I and IL-12, aswell as limiting viral replication within pDCs early after in vivo
infection.
TLR7 Was Required for Full Activation of Innate and
Adaptive Immune Cells Early after LCMV Cl13 Infection
We next investigated the activation status of other innate (cDCs
and NK cells) as well as adaptive (CD4+ and CD8+ T cells)
immune cells in TLR7/ and WT infected mice. In contrast to
pDCs, the numbers of IL-12- and TNFa-producing cDCs and
macrophages were not affected, or were slightly increased, by
TLR7 deficiency (Figure 7A). However, we observed that both
TLR7/ cDCs and macrophages exhibited lower expression
of MHCII, CD86, and PDL1 compared with their WT counter-
parts, although these cells were still more matured compared
to uninfected controls (Figures 7B–7D). Similarly, expression of
the early activation marker CD69 was significantly upregulated
in NK, CD4+, and CD8+ T cells from WT infected versus30, June 14, 2012 ª2012 Elsevier Inc. 623
Figure 6. pDCs Sense In Vivo LCMV Cl13 Infection through TLR7
WT or TLR7/mice were left uninfected or infected withWT LCMVCl13, and serum (A) or spleens (B–G) were processed at day 1 p.i. (A) Serum IFN-I activity was
measured by luciferase bioassay. (B–D) pDCs, CD11b+ and CD8+ cDCs, and macrophages were FACS purified from spleens pooled from four to five mice per
group. Ifna and ifnb transcript levels were determined relative to gapdh by qPCR. (B) pDCs were cultured and supernatants collected at 15 hr to measure IFN-I
bioactivity, where dotted line indicates limit of bioassay detection (C), or IL-12p70 levels (D). (E) The percentage of IL-12p40+ and TNFa+ pDCswas determined by
flow cytometry. Representative dot plots are shown. (F) MHC II, CD86, and PDL1 expression was analyzed in pDCs by flow cytometry. MFI ± SD are graphed
where symbols represent individual mice. Representative histogram of uninfected (gray solid), and Cl13 infected WT (gray unfilled) and TLR7/ (black unfilled)
mice are shown. (G) LCMV gp and np transcripts were quantified in FACS-purified pDCs by qPCR. All bar graphs depictmean ± SD, and data are representative of
two to three independent experiments with three to five mice per group. *p < 0.05, **p < 0.001, ***p < 0.0001.
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TLR7/ infected mice (Figure 7E). Overall, these results indi-
cated that TLR7 exerted a global effect in orchestrating innate
and adaptive immune cells early after LCMV Cl13 infection.
DISCUSSION
It is well established that the initial interactions between a path-
ogen and its host can drastically influence the outcome of
an infection. We characterized the early events that unfold
upon in vivo exposure with a prototypic member of the family
Arenaviridae, which includes causative agents of fatal hemor-624 Cell Host & Microbe 11, 617–630, June 14, 2012 ª2012 Elsevierrhagic fevers, as well as established models for studying antiviral
immunity. Our data unveiled pDCs as an early target for produc-
tive arenavirus replication, situating this cell type at the center of
the virus-host battle during the onset of an in vivo infection.
DCs express high levels of functional a-DG and have been
defined as major targets of Old World arenaviruses in mice and
humans, an event related to DC functional impairment and
T cell suppression (Baize et al., 2004; Pannetier et al., 2011;
Sevilla et al., 2003). More recently, using infection of GFP
reporter transgenic mice with a replication-deficient LCMV
vector, GFP expression was exclusively detected in DCs, partic-
ularly PDCA+CD11cint cells (Bergthaler et al., 2010). ThisInc.
Figure 7. TLR7 Mediates Early Activation of Innate and Adaptive Immune Cells
WT or TLR7/ mice were left uninfected or infected with WT LCMV Cl13, and spleens were processed at day 1 p.i. (A) The percentage of IL-12+ and TNFa+
CD11b+ andCD11bcDCs, andmacrophageswas determined by flow cytometry. Representative dot plots are shown. Bar graph depicts mean ± SD. (B–D)MHC
II, CD86, and PDL1 expression was analyzed in CD11b+cDCs (B), CD11bcDCs (C), andmacrophages (D) by flow cytometry. (E) NK, CD4+, and CD8+T cells were
analyzed by flow cytometry for expression of CD69. Representative histogram of uninfected (gray solid), and Cl13 infected WT (gray unfilled) and TLR7/ (black
unfilled) mice are shown. Graphs depict mean MFI ± SD. All results are representative of three to four independent experiments with three to five mice per group.
*p < 0.05, **p < 0.001, ***p < 0.0001.
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Early Responses against a pDC-Tropic Virusobservation suggests that pDCs are the initial targets of LCMV,
but it remained open whether pDCs could support a productive
viral cycle. By using a stringent pDC purification protocol
coupled with infectious center assay, we demonstrated that,
as early as 1 day after in vivo exposure with LCMV Cl13, pDCs
produced significantly more infectious viral particles than any
other leukocyte analyzed in this study, suggesting their potential
role in initial viral propagation. Our data also showed that pDCs
expressed higher levels of OldWorld arenavirus-binding proteins
than cDCs, providing an explanation for why pDCs are preferen-
tially targeted by LCMV Cl13 (and possibly LASV) in vivo.
IFN-I plays a crucial role in virus control and induction of virus-
specific T cells in several infections, including those with single-
stranded (ss) RNA viruses such as LCMV (Muller et al., 1994; van
den Broek et al., 1995), influenza virus (Wiesel et al., 2011), HCV
(Missale et al., 1997; Rodrigue-Gervais et al., 2010), and HIV
(Meyers et al., 2007). Consistently, a complex and often overlap-
ping molecular network is in place to secure rapid viral sensing
and IFN-I production. In particular, ssRNA viruses can trigger
IFN-I production mainly through the cytoplasmic RIG-I/MAVS/
IRF3 pathway and the endosomal TLR7/MyD88/IRF7 pathway,
the latter operating exclusively in pDCs (Thompson et al.,
2011). However, most viruses have evolved strategies to coun-
teract IFN-I production and signaling to favor their own replica-
tion and transmission (Garcia-Sastre and Biron, 2006). Thus,
a common query for many viral infections is how IFN-I is elevated
in vivo despite the inhibitory activity of viral products. In that re-
gard, NPs from most arenaviruses inhibit IFN-I production
(Martinez-Sobrido et al., 2007), but IFN-I is still elevated early
after infection (Lee et al., 2009; Louten et al., 2006; Zuniga
et al., 2008). Several studies have attributed the cellular source
of IFN-I during LCMV infection to marginal zone macrophages
(Louten et al., 2006), cDCs, and pDCs (Dalod et al., 2002; Diebold
et al., 2003; Jung et al., 2008; Lee et al., 2009; Montoya et al.,
2005; Zhou et al., 2010) under conditions that result in acute viral
clearance. We found that pDCs were a powerful early source of
IFN-I in several lymphoid tissues after infection with DC-tropic
LCMV Cl13, which establishes chronic infection (Ahmed et al.,
1984). Remarkably, and in contrast to cDCs, pDCs did not
require intrinsic LCMV replication to produce IFN-I, and, indeed,
uninfected pDCs were quantitatively a major leukocyte source of
IFN-I, supporting previous data demonstrating IFN-I production
by uninfected pDCs during infection with murine cytomegalo-
virus (MCMV) (Dalod et al., 2003) or Newcastle disease virus
(Kumagai et al., 2009). On the other hand, a fraction of infected
pDCs (and cDCs) also produced IFN-I, but the vast majority
did not, possibly due to the inhibitory effect of the arenavirus
NP (Martinez-Sobrido et al., 2006). These data suggest that
pDCsmay have evolvedmeans to sense virus infection indepen-
dent of intrinsic replication. In this regard, a cell-to-cell RNA
transfer process during which HCV-infected cells induce pDC
IFN-I production, without infecting them, has been reported
(Takahashi et al., 2010). To date, the TLRs involved in sensing
LCMV to initiate in vivo IFN-I production remain controversial.
TLR2ko mice, but not 3D mice which exhibit impaired TLR3,
TLR7, and TLR9 responses, showed reduced IFN-I upregulation
upon in vivo infection with LCMV (Zhou et al., 2005). In contrast,
another study reported that IFN-I responsewas partially inhibited
in TLR7 and TLR9 double KO mice (but not TLR2ko mice) and626 Cell Host & Microbe 11, 617–630, June 14, 2012 ª2012 Elsevierproposed that pDCs recognize LCMV partially through an
unknown receptor that signals through MyD88 (Jung et al.,
2008).Our data clearly indicated that TLR7wasabsolutely essen-
tial for pDC IFN-I production and partially required for systemic
IFN-I elevation after in vivo LCMV Cl13 infection. Importantly,
while pDC IFN-I was completely ablated in TLR7/ infected
mice, substantial amounts of systemic IFN-I were still detected,
indicating that other cell types significantly contribute to systemic
IFN-I elevation early after in vivo infection, as previously reported
(Dalod et al., 2002; Louten et al., 2006; Swiecki et al., 2010).
Not only were pDCs able to produce substantial levels of IFN-I,
but they also secreted multiple other cytokines and chemokines
in response to in vivo LCMV Cl13 infection. In particular, IL-12
was mainly secreted by pDCs in a TLR7-dependent fashion.
This is in agreement with previous studies in MCMV infection
that demonstrated pDCs are a major source of both IFN-I and
IL-12, although the source of IL-12 (but not IFN-I) can be
substituted by other DC subsets (Dalod et al., 2002, 2003;
Krug et al., 2004). Here we observed that a proportion of IFN-I-
producing pDCs simultaneously synthesized IL-12, and to
a lower extent TNF-a, uncovering multicytokine-producing
pDCs that arise early after in vivo LCMV Cl13 infection, as has
been observed after MCMV infection (Zucchini et al., 2008).
Furthermore, while CD11b+cDCs and CD8+cDCs exhibited
strong antigen-presenting capacity early after LCMV Cl13 infec-
tion, pDCs remained poor antigen-presenting cells. The prefer-
ential antigen presentation of CD8+ cDCs to CD8+ T cells and
CD11b+ cDCs to CD4+ T cells is in agreement with previous
work demonstrating that these cDC subsets are equipped to
better present MHC I or II antigens, respectively (Dudziak
et al., 2007). pDCs may instead play an indirect role in the initial
activation of innate and adaptive immune cells through IL-12 and
IFN-I production. Although we did not directly link pDC cytokine
production with the early activation of immune cells during LCMV
Cl13 infection, the well-established role of both IL-12 and IFN-I in
this process (Biron et al., 2002; Swiecki and Colonna, 2011), as
well as the diminished activation of cDCs, NK cells, and T cells
that we observed in TLR7/ mice, supports this possibility. In
this regard, a recent study demonstrates that pDC depletion
by conditional targeting of the E2-2 transcription factor results
in impaired antiviral T cell responses and failure to control persis-
tent LCMVDocile infection (Cervantes-Barragan et al., 2012). On
the other hand, another report shows that pDC depletion in
BDCA2-DTR transgenic mice infected with persistent LCMV
Cl13 causes no effect on CD8 T cell responses and only slight
increases in viral load at 48 hr p.i. (Wang et al., 2012). Nonethe-
less, we and others demonstrated that pDC numbers and their
IFN-I production capacity are severely reduced by day 5 after
LCMV Cl13 infection (Lee et al., 2009; Zuniga et al., 2008), sug-
gesting that understanding the mechanisms involved in pDC
suppression may illuminate strategies to prolong pDC-derived
IFN-I responses and promote a more potent antiviral response.
Finally, our results indicated that TLR7 signaling limited viral
loads in pDCs at a time when they were a niche for produc-
tive infection. These findings were consistent with previous
reports demonstrating that TLR7 controls immune responses
during infection with other ssRNA viruses (Diebold et al., 2003;
Hornung et al., 2005; Lund et al., 2004; Schlaepfer et al.,
2006). Furthermore, another study shows that TLR7/ miceInc.
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immune response during chronic LCMV infection (Walsh et al.,
2012). This study, together with our results, points to the TLR7
pathway as a potential target to improve control of Old World
arenaviruses.
Our study uncovered pDCs as a preferential leukocyte target
for productive virus replication and a powerful source of antiviral
and proinflammatory cytokines during in vivo infection with
a prototypic Old World arenavirus. This situates the pDC as
a double-edged sword in the virus-host competition that takes
place early (and that may influence later events) during infection
with arenaviruses and potentially other DC-tropic viruses.
EXPERIMENTAL PROCEDURES
Mice and Viral Stocks
WTC57Bl/6 and IFNbmob/mob mice were purchased from The Jackson Labora-
tory (Bar Harbor, ME). TLR7/ mice were described previously (Lund et al.,
2004). Mice were bred andmaintained in a closed breeding facility, andmouse
handling complied with the requirements of the National Institutes of Health
and the Institutional Animal Care and Use Guidelines of the University of Cali-
fornia San Diego. Six- to ten-week-old mice were infected intravenously with
2 3 106 pfu/mL WT LCMV Cl13 or LCMV Armstrong 53b (ARM), or 4.5 3 105
pfu/mL r3LCMVCl13-GFP (Emonet et al., 2009). All viruses were grown, iden-
tified, and quantified as previously described (de la Torre and Oldstone, 1992).
Cell Purification
Spleens were incubated with collagenase D (1 mg/mL, Roche, Indianapolis,
IN) for 20 min at 37C and passed through a 100 mm strainer to achieve
a single-cell suspension. Splenocytes were enriched with PanDC or PDCAmi-
crobeads using an Automacs system (Miltenyi, Auburn, CA). PanDC+ fractions
were FACS purified using a BD ARIA (BD Biosciences, San Jose, CA) for
pDCs (CD11cintermediate/dimCD11bB220+PDCA+),CD8+ cDCs (CD11c+B220
CD11bCD8+), and CD11b+ cDCs (CD11c+B220CD11b+CD8) after B
(CD19), T (Thy1.2), and NK (Nk1.1) cell exclusion. PanDC fractions were
FACS purified for macrophages (CD19Thy1.2NK1.1CD11cCD11b+) and
B/T cells (Thy1.2+CD19+). WT Cl13 infected IFNbmob/mob pDCs were FACS
purified for IFNb-producing (pDC YFP+) and nonproducing (pDC YFP) cells.
Purity for all cell types was >94%.
Flow Cytometry
Antibodies used were purchased from Ebioscience or BD PharMingen (San
Diego, CA) to stain splenocytes: CD19 PE, efluor450, or PercpCy5.5; Thy1.2
PE, efluor450, or PercpCy5.5; NK1.1 PE, efluor450, or PercpCy5.5; CD11c
APC or Alexa700; PDCA1 FITC or PE; CD11b PercpCy5.5, PECy7, or APC;
B220 APC-efluor780, IL-12p40 Alexa647, and TNFa efluor450. Cells were pre-
incubated with CD16/CD32 Fc block (BD PharMingen). Anti-LCMV-NP (clone
113) was a gift from M. Oldstone (TSRI). Surface and intracellular cytokine
staining was performed as previously described (Zuniga et al., 2004). Samples
were acquired on a BD LSR II (BD Biosciences) and analyzed using FlowJo
software (Treestar, Inc., Ashland, OR).
Virus Overlay Assay
pDCs and cDCswere generated fromBMcells in the presence of fms-like tyro-
sine kinase receptor-3 ligand (Flt3L; 100 ng/ml) or GM-CSF (200 IU) as previ-
ously described (Zuniga et al., 2004). For virus overlay assay, proteins were
separated by SDS-PAGE, blotted to nitrocellulose, and incubated with purified
LCMV Cl13 and VSV pseudoparticles expressing LASV GP at 107 PFU/ml.
Bound virus was detected with mAb 83.6 to LCMV GP2 using an HRP-
conjugated secondary antibody and ECL for detection as described (Kunz
et al., 2005).
Virus Binding Assay
3 3 105 cells (pDCs, CD8+ cDCs, and CD11b+ cDCs) were lysed in
50 mM HEPES (pH 7.5)/150 mM NaCl/1% NP-40/1.2 mM EDTA/5 mM
MgCl2, 5 mM CaCl2/protease inhibitor cocktail complete (Roche), andCell H1 mM PMSF. Lysates were cleared and subjected to affinity purification with
wheat germ agglutinin (WGA) as described (Michele et al., 2002). Eluted
glycoproteins were immobilized in 96-well microtiter (EIA/RIA) high-bond
plates, and nonspecific binding was blocked with 1% (w/v) BSA/PBS for
1 hr at room temperature (RT). LCMV Cl13 and recombinant LCMV
expressing the GP of LASV (Rojek et al., 2008) were purified over
a renografin gradient and diluted in 1% (w/v) BSA/PBS to 107 PFU/ml. Virus
was incubated overnight (O/N) on a shaker, unbound virus removed by
washing, and bound virus was detected with mAb 83.6 to LCMV GP2 with
a biotinylated secondary antibody and streptavidin-HRP in a color reaction
with 2,20azino-bis(3-ethylbenzthiazoline-6-sulfonic acid [ABTS]). Jurkat cells,
which are negative for LASV receptors and refractory to infection, were used
as negative controls.
Antigen-Presentation Assay
2.5 3 104 FACS-purified DCs were cocultured with 5 3 104 naive CFSE-
labeled TCR transgenic P14+ or SMARTA+T cells enriched to >90% by nega-
tive selection (Stem Cell Technology, Vancouver, Canada). Seventy-two hours
later, T cells were restimulated with cognate peptide GP33-41 (P14) or GP67-77
(SMARTA) for 5 hr in the presence of brefeldin A (BFA) and analyzed for CFSE
dilution and intracellular cytokine production of IFNg, TNFa, and IL-2 by flow
cytometry (BD LSRII).
Immunofluorescence
Snap-frozenOCT embedded spleens fromWTCl13 infected IFNbmob/mobmice
were cut into 6 mm sections using a cryostat (Leica, Buffalo Grove, IL) and
mounted onto glass slides. Sections were fixed by 4% paraformaldehyde
RT 15 min, permeabilized with 0.2% NP-40 in 13 PBS + 5% BSA 5 min RT,
blocked 30 min RT with image iT Fx signal enhancer (Invitrogen, Carlsbad,
CA), and incubated O/N at 4C with guinea pig anti-LCMV (1:200) and
rabbit anti-GFP antibodies (1:100, Cell Signaling, Danvers, MA). Rhodamine
RedX-conjugated donkey anti-guinea pig (1:200, Jackson Immunoresearch,
Westgrove, PA) and FITC conjugated anti-rabbit Ig (1:50, eBioscience)
secondary antibodies were incubated with sections for 1 hr. Nuclei were
stained with DAPI (1:1,000, Sigma Aldrich, St. Louis, MO) for 5 min at RT prior
to mounting. Sections were imaged at 1003 magnification on an Olympus
FV1000 Confocal Microscope and analyzed using FV10-ASW v3.0 viewer
software.
Infectious Center Assay
Two-fold dilutions of FACS-purified splenocytes were prepared and incubated
on a Vero cell monolayer with rotation for 1 hr at 37C. Monolayers were then
overlayed with 1% agarose and incubated 6 days at 37C. Release of viral
progeny determined as plaques formed was quantified and extrapolated
as number of plaques per million cells as described previously (Doyle and
Oldstone, 1978).
Cytokine Measurements
For cytokine measurement in culture supernatants, 50,000 FACS-purified
pDCs were cultured for 15 hr at 37C. IFN-I bioactivity was measured with
reference to a recombinant mouse IFNb standard (Research Diagnostics,
Concord, MA) using a L-929 cell line transfected with an interferon-sensitive
luciferase (Jiang et al., 2005). IL-12p70, TNFa, IL-1a, MCP1, MIP1a, and
RANTESweremeasured in culture supernatants by luminex array using ready-
made MILLIPLEX mouse cytokine panel I and II kits (Millipore, Billerica, MA) as
described previously (Harker et al., 2011). To measure intracellular cytokines
by flow cytometry, splenocytes were incubated in complete media + BFA for
4 hr at 37C prior to staining.
Quantitative Real-Time RT-PCR Analysis
Total RNA was extracted from purified cells using RNeasy Microkit (QIAGEN,
Valencia, CA), digested with DNase I, and reverse transcribed into cDNA
(Superscript III, Invitrogen, Carslbad, CA). Quantification of cDNA was per-
formed using SYBR Green PCR Kit and Real-Time PCR Detection System
(Applied Biosystem, Carlsbad, CA). The relative RNA levels were normalized
against gapdhRNA as described previously (Zuniga et al., 2008). The following
primers were used: LCMV glycoprotein (LCMVsSgp1), F 50-CATTCACCTG
GACTTTGTCAGACTC-30, R 50-GCAACTGCTGTGTTCCCGAAA-30; LCMVost & Microbe 11, 617–630, June 14, 2012 ª2012 Elsevier Inc. 627
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Early Responses against a pDC-Tropic Virusnucleoprotein (LCMVsSgp2), F 50-GCATTGTCTGGCTGTAGCTTA-30, R 50-
CAATGACGTTGTACAAGCGC-30; ifna primers recognizing ifna 4, 6, 7, F
50-TATGTCCTCACAGCCAGCAG-30, R 50-TTCTGCAATGACCTCCATCA-30;
ifnb1, F 50-CTGG CTTCCATCATGAACAA-30 R 50-AGAGGGCTGTGGTGGA
GAA-3.
Statistical Analysis
Statistical differences were determined by one-way or two-way analysis of
variance (ANOVA) or Student’s t test using the InStat 3.0 software (Graphpad,
La Jolla, CA).
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